Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03128476
Other study ID # BEC
Secondary ID
Status Completed
Phase N/A
First received February 20, 2017
Last updated April 20, 2017
Start date March 3, 2016
Est. completion date January 30, 2017

Study information

Verified date February 2017
Source Sprim Advanced Life Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In Southeast Asia, Essence of Chicken, a chicken-meat-extract, is a popular beverage and is consumed as a traditional remedy for several ailments, including the use as a nutritional supplement for sickness, enhancement of mental efficiency, and recovery from mental fatigue. While the elderly use it as a nutritional supplement, students use it for relief from anxiety during exam times.

The present study is conducted in order to assess the effects of BEC on various physical and mental parameters including physical fatigue, working memory and attention, mood and stress, in comparison to placebo.


Recruitment information / eligibility

Status Completed
Enrollment 364
Est. completion date January 30, 2017
Est. primary completion date November 7, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Normal BMI

- Not continuously taken Essence of Chicken for the last 3 months

- Physical and psychological fatigue inclusion criteria/test/cutoff using CFQ (where individuals' CFQ scores 4 or above)

Exclusion Criteria:

- Suffering from chronic or malignant diseases e.g. cancer, heart, liver, renal or other metabolic diseases.

- Any psychiatric or neurological disease

- Pregnant and lactating women

- Subjects participated in any investigational drug trial within 4 weeks before screening

- Consumption of food supplement in the previous 2 weeks

- Professional athletes

- Subjects with recent lifestyle changes in the past 4 weeks

- History of allergy to chicken meat and seafood

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Essence of Chicken
Brand's Essence of Chicken (BEC) is produced via a water extraction process from chicken meat for several hours under high-temperature, followed by centrifugation to remove fat and cholesterol, vacuum concentration to 3- to 4-fold, sterilization by high temperature and pressure before bottling. This kind of chicken essence is rich in protein, and low in sugar and fat, conveniently available and consumable, and easy for household storage.
Placebo (Energy matched)


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Sprim Advanced Life Sciences Cerebos

Outcome

Type Measure Description Time frame Safety issue
Primary Fatigue-vitality Psychometric tests SF-36 (score 100%) 4 weeks
Primary Physical fatigue Chalder Fatigue Questionnaire (score 0-33) 4 weeks
Primary Attention Stroop (mean latency and proportion correct) 4 weeks
Primary Sustained attention Sustained Attention to Response Task (mean latency and % of correct trials) 4 weeks
Primary Working memory Digit Span test (Maximal FORWARD digit span and Maximal BACKWARD digit span, etc) 4 weeks
Secondary Mood POMS brief is used as a psychometric test to measure mood (6 domains). 4 weeks
Secondary Stress DASS is used as a psychometric test to measure stress (score 0-42). 4 weeks
Secondary Adverse effects Comparison of adverse events on IP and placebo groups. 4 weeks
See also
  Status Clinical Trial Phase
Completed NCT05483998 - A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants Phase 1
Recruiting NCT02417714 - Prospective Evaluation of Next Generation CT Reconstruction (NextGenIR)
Recruiting NCT02235012 - Cognitive Biases Under Ketamine N/A
Completed NCT05088343 - Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Phase 1
Completed NCT04418973 - Analysis of Breath Volatile Organic Compounds After Dyspnea Induced in the Healthy Subject. N/A
Not yet recruiting NCT06248801 - Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets Phase 1
Terminated NCT04068259 - Single Ascending Dose Study of PBI-4547 in Healthy Subjects Phase 1
Completed NCT03279302 - Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects Phase 1
Not yet recruiting NCT06233162 - Febuxostat 80 mg Tablets Relative to Feburic® 80 mg Tablets Phase 1
Recruiting NCT04159844 - Evaluation of the Stiffness and Pressure Applied on the Lower Leg by a New Compression Bandage on Healthy Subjects N/A
Completed NCT06137911 - Evaluation of Safety, Tolerability & Pharmacokinetics of JYP0061 in Healthy Adults. Phase 1
Completed NCT04849286 - Measurement of HTL0016878 in Cerebrospinal Fluid Phase 1
Not yet recruiting NCT06233227 - Dutasteride Soft Capsule 0.5 mg Relative to Avodart 0.5 mg Soft Capsule Phase 1
Completed NCT04096157 - A Study to Assess Isavuconazole Following a Single Dose of Isavuconazonium Sulfate Intravenous Solution Via Nasogastric (NG) Tube Compared to a Single Dose of Oral Capsules Under Fasting Conditions in Healthy Participants Phase 1
Completed NCT01200368 - Trial Evaluating a 13-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants Phase 3
Recruiting NCT05805033 - Peri-Implant Soft Tissue Integration in Humans: Influence of Material N/A
Completed NCT04027803 - Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of Single Intravenous Doses of BCD-148 and Soliris® Phase 1
Recruiting NCT03467880 - Multicenter Study of Impulse Oscillometry in Chinese N/A
Completed NCT02903095 - Single Ascending Dose Study of TD-1439 in Healthy Subjects Phase 1
Active, not recruiting NCT02341508 - A Phase 1a, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate Lpathomab in Healthy Volunteers Phase 1